<?xml version="1.0" encoding="utf-8"?>
<Return>
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2018-12-27T09:18:53-07:00</ReturnTs>
    <TaxPeriodEndDt>2018-07-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>043341506</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>JULIAN B FRIEDMAN CPA</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>100 GALEN ST STE 101</AddressLine1Txt>
        <CityNm>WATERTOWN</CityNm>
        <StateAbbreviationCd>MA</StateAbbreviationCd>
        <ZIPCd>024724502</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2017-08-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>042932269</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>THE CANCER CENTER RESEARCH</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>FOUNDATION</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>CANC</BusinessNameControlTxt>
      <PhoneNum>6717545320</PhoneNum>
      <USAddress>
        <AddressLine1Txt>1184 SOUTH SUMMIT DRIVE</AddressLine1Txt>
        <CityNm>SANTA FE</CityNm>
        <StateAbbreviationCd>NM</StateAbbreviationCd>
        <ZIPCd>87501</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>MURRAY BERN MD</PersonNm>
      <PersonTitleTxt>DIRECTOR</PersonTitleTxt>
      <PhoneNum>6717545320</PhoneNum>
      <SignatureDt>2018-12-12</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>JULIAN FRIEDMAN</PreparerPersonNm>
      <PTIN>P00252746</PTIN>
      <PhoneNum>6172676969</PhoneNum>
      <PreparationDt>2018-12-13</PreparationDt>
    </PreparerPersonGrp>
    <FilingSecurityInformation>
      <IPAddress>
        <IPv4AddressTxt>75.144.172.109</IPv4AddressTxt>
      </IPAddress>
      <IPDt>2018-12-27</IPDt>
      <IPTm>10:18:53</IPTm>
      <IPTimezoneCd>CS</IPTimezoneCd>
      <FilingLicenseTypeCd>P</FilingLicenseTypeCd>
      <AtSubmissionCreationDeviceId>2484215340F079EF64EF988D15E460CA00D4B16D</AtSubmissionCreationDeviceId>
      <AtSubmissionFilingDeviceId>42CD623E8E638D924825D4355AB972BF7A66D724</AtSubmissionFilingDeviceId>
    </FilingSecurityInformation>
    <TaxYr>2017</TaxYr>
    <BuildTS>2019-02-21 02:37:17Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="3">
    <IRS990 documentId="RetDoc1" referenceDocumentId="RetDoc3">
      <PrincipalOfficerNm>MURRAY BERN MD</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>1184 SOUTH SUMMIT DRIVE</AddressLine1Txt>
        <CityNm>SANTA FE</CityNm>
        <StateAbbreviationCd>NM</StateAbbreviationCd>
        <ZIPCd>87501</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>1042</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>N/A</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1986</FormationYr>
      <LegalDomicileStateCd>MA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>THE FOUNDATION PERFORMS DEEP STUDIES OF SELECTED AREAS OF ONCOLOGY AND HEMATOLOGICAL INVESTIGATION AND CARE. THE FOUNDATION SUPPORTS EFFORTS TO BETTER UNDERSTAND THE MECHANISM AND PREVENTION OF THE EVER INCREASING PROBLEM OF PATHOLOGICAL VENOUS THROMBOSIS (DVT) AND PULMONARY EMBOLI (PE) AMONG CANCER AND SURGICAL PATIENTS.MORE PEOPLE DIE FROM PE THAN FROM BREAST CANCER,AIDS AND AUTO ACCIDENTS COMBINED.IT IS THE FOUNDATION PLAN TO DETERMINE THRU VARIOUS ACTIVITIES THE EXACT MECHANISMS THAT ACITIVATES THE FORMATION OF THE PATHOLOGICAL THROMBUS (PE)ON ANY GIVEN DAY AND WHAT MAY CONTROL THE SIZE OF THE CLOT.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>1</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>1</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>1</TotalEmployeeCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <CYContributionsGrantsAmt>30</CYContributionsGrantsAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>2271</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>1012</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>339</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>2610</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>1042</CYTotalRevenueAmt>
      <CYGrantsAndSimilarPaidAmt>0</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>159530</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>160200</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>8155</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>6501</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>167685</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>166701</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-165075</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-165659</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>292925</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>127253</TotalAssetsEOYAmt>
      <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>292925</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>127253</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>THE FOUNDATION PERFORMS DEEP STUDIES OF SELECTED AREAS OF ONCOLOGY AND HEMATOLOGICAL INVESTIGATION AND CARE. THE FOUNDATION SUPPORTS EFFORTS TO BETTER UNDERSTAND THE MECHANISM AND PREVENTION OF THE EVER INCREASING PROBLEM OF PATHOLOGICAL VENOUS THROMBOSIS (DVT) AND PULMONARY EMBOLI (PE) AMONG CANCER AND SURGICAL PATIENTS.MORE PEOPLE DIE FROM PE THAN FROM BREAST CANCER,AIDS AND AUTO ACCIDENTS COMBINED.IT IS THE FOUNDATION PLAN TO DETERMINE THRU VARIOUS ACTIVITIES THE EXACT MECHANISMS THAT ACITIVATES THE FORMATION OF THE PATHOLOGICAL THROMBUS (PE)ON ANY GIVEN DAY AND WHAT MAY CONTROL THE SIZE OF THE CLOT.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <Desc>DR. MURRAY BERN COMPLETED THE ANALYSIS OF DATA, MANUSCRIPT PREPARATION AND SUBMISSION TO JOURNALS OF DATA DEALING WITH THE CLOTTING SYSTEM, DEEP VEIN THROMBOSOS AND TRANSFUSION MEDICINE. THIS WORK LED TO PUBLICATIONS IN THREE SCIENTIFIC JOURNALS. IT ALSO SET THE STAGE FOR FURTHER RESEARCH BY FELLOWS OF THE ONCOLOGY SERVICE AND HIS OWN FURTHER WORK LOOKING IN DEEPER DETAIL INTO THE CLOTTING SYSTEM FOR PATIENTS HAVING CANCERS. TWO OF THE SUCCESSFUL RESEACH PROJECTS DEMONSTRATED HOW TO BEST USE BLOOD STUDY MARKERS FOR DEMONSTRATING THE OPTIMAL USE OF DRUGS TO PREVENT CLOTTING (IN THIS CASE DEEP VEIN THROMBOSOS OF THE LEGS) AND HOW ONE MIGHT BEST USE SOME OF THE AVAILABLE DRUGS SO AS TO REDUCE THE RISK OF BLEEDING WITH THE ANTICOAGULANTS.</Desc>
      <ProgSrvcAccomActy2Grp>
        <Desc>THE THIRD RESEARCH PROJECT DEMONSTRATED HOW IN THE POST-OPERATIVE SETTING THERE IS OFTEN AN OVERUSE OF HYDRATING FLUIDS LIKE SALINE AND GLICOSE THAT LEADS TO DILUTION OF THE BLOOD AND AN IATROGENIC WORSENING OF ANEMIA, WHICH THEN CREATES THE APPEARANCE THAT TRANSFUSION OF BLOOD IS NEEDED. THE NEXT PHASE OF STUDY WILL BE DIRECTED AT DEVELOPING A DEEPER UNDERSTANDING OF WHY CLOTS, SUCH AS DEEP VEIN THROMBI OF THE ARMS AND LEGS, OCCUR MORE OFTEN AMONG PATIENTS WITH CANCER. THE WORK WILL FOCUS UPON WHETHER FRAGMENTS OF NORMAL AND CANCEROUS CELLS, CALLED EXTRACELLULAR VESICLES(EVS), CAN BE A NIDUS OR CATALYST FOR THOSE CLOTS TO FORM AND WORSEN WITHIN OTHERWISE NORMAL VEINS.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <Desc>SPECIFICALLY, THE WORK WILL EXAMINE WHETHER MOLECULES THAT ARE EXPOSED ON THE SURFACE OF THE EV'S (PHOSPHATIDYLSERINE) CAUSE THEM TO DOCK ON THE LINING CELLS OF THE VEINS AT AN INCREASED RATE OR DENSITY. THE WORK WILL USE A SPECIAL LABORATORY TECHNIQUE CALLED PHAGE DISPLAY TO EXPLORE THIS QUESTION. THE FIRST PHASE OF THIS WORK WAS STARTED IN THE PAST YEAR CREATING A SERIES OF FOCUSED SCIENTIFIC QUESTIONS, EXAMINING AND SELECTING ALREADY PUBLISHED TECHNIQUES IN THE FIELD AND GATHERING NEEDED SUPPORT OF OTHER RELEVANT BASIC SCIENCE INVESTIGATIORS.</Desc>
      </ProgSrvcAccomActy3Grp>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc4">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd>false</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
      <ConservationEasementsInd>false</ConservationEasementsInd>
      <CollectionsOfArtInd>false</CollectionsOfArtInd>
      <CreditCounselingInd>false</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd>false</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd>false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd>false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd>false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd>false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd>false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd>false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd>false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd>false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd>false</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>false</ScheduleORequiredInd>
      <IRPDocumentCnt>0</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>1</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>1</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>1</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>false</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>false</ConflictOfInterestPolicyInd>
      <WhistleblowerPolicyInd>false</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>false</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>false</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>MA</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>MURRAY BERN MD</PersonNm>
        <PhoneNum>6177545320</PhoneNum>
        <USAddress>
          <AddressLine1Txt>1184 SOUTH SUMMIT DRIVE</AddressLine1Txt>
          <CityNm>SANTA FE</CityNm>
          <StateAbbreviationCd>NM</StateAbbreviationCd>
          <ZIPCd>87501</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>MURRAY BERN MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>150000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>150000</TotalReportableCompFromOrgAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <AllOtherContributionsAmt>30</AllOtherContributionsAmt>
      <TotalContributionsAmt>30</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>1012</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1012</RelatedOrExemptFuncIncomeAmt>
      </InvestmentIncomeGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>1042</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1012</RelatedOrExemptFuncIncomeAmt>
      </TotalRevenueGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>150000</TotalAmt>
        <ManagementAndGeneralAmt>150000</ManagementAndGeneralAmt>
      </CompCurrentOfcrDirectorsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>10200</TotalAmt>
        <ManagementAndGeneralAmt>10200</ManagementAndGeneralAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>2750</TotalAmt>
        <ManagementAndGeneralAmt>2750</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <OtherExpensesGrp>
        <Desc>DUES &amp; PUBLICATIONS</Desc>
        <TotalAmt>1965</TotalAmt>
        <ManagementAndGeneralAmt>1965</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>PAYROLL FEES</Desc>
        <TotalAmt>1536</TotalAmt>
        <ManagementAndGeneralAmt>1536</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>FILING FEE</Desc>
        <TotalAmt>250</TotalAmt>
        <ManagementAndGeneralAmt>250</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>166701</TotalAmt>
        <ProgramServicesAmt>0</ProgramServicesAmt>
        <ManagementAndGeneralAmt>166701</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>40800</BOYAmt>
        <EOYAmt>51219</EOYAmt>
      </CashNonInterestBearingGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>252125</BOYAmt>
        <EOYAmt>76034</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <TotalAssetsGrp>
        <BOYAmt>292925</BOYAmt>
        <EOYAmt>127253</EOYAmt>
      </TotalAssetsGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrgDoesNotFollowSFAS117Ind>X</OrgDoesNotFollowSFAS117Ind>
      <PdInCapSrplsLandBldgEqpFundGrp>
        <BOYAmt>100</BOYAmt>
        <EOYAmt>100</EOYAmt>
      </PdInCapSrplsLandBldgEqpFundGrp>
      <RtnEarnEndowmentIncmOthFndsGrp>
        <BOYAmt>292825</BOYAmt>
        <EOYAmt>127153</EOYAmt>
      </RtnEarnEndowmentIncmOthFndsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>292925</BOYAmt>
        <EOYAmt>127253</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>292925</BOYAmt>
        <EOYAmt>127253</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>-165659</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>-13</NetUnrlzdGainsLossesInvstAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>false</FSAuditedInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc4">
      <MedicalResearchOrganizationInd>X</MedicalResearchOrganizationInd>
      <HospitalNameAndAddressGrp>
        <SupportedOrganizationName>
          <BusinessNameLine1Txt>UNIVERSITY OF NEW MEXICO CANCER CENTER</BusinessNameLine1Txt>
        </SupportedOrganizationName>
        <CityNm>ALBUQUERQUE</CityNm>
        <StateAbbreviationCd>NM</StateAbbreviationCd>
      </HospitalNameAndAddressGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleO documentId="RetDoc3">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 - ORGANIZATION'S MISSION</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION PERFORMS DEEP STUDIES OF SELECTED AREAS OF ONCOLOGY AND HEMATOLOGICAL INVESTIGATION AND CARE. THE FOUNDATION SUPPORTS EFFORTS TO BETTER UNDERSTAND THE MECHANISM AND PREVENTION OF THE EVER INCREASING PROBLEM OF PATHOLOGICAL VENOUS THROMBOSIS (DVT) AND PULMONARY EMBOLI (PE) AMONG CANCER AND SURGICAL PATIENTS.MORE PEOPLE DIE FROM PE THAN FROM BREAST CANCER,AIDS AND AUTO ACCIDENTS COMBINED.IT IS THE FOUNDATION PLAN TO DETERMINE THRU VARIOUS ACTIVITIES THE EXACT MECHANISMS THAT ACITIVATES THE FORMATION OF THE PATHOLOGICAL THROMBUS (PE)ON ANY GIVEN DAY AND WHAT MAY CONTROL THE SIZE OF THE CLOT.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>NO REVIEW WAS OR WILL BE CONDUCTED.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XI, LINE 9</FormAndLineReferenceDesc>
        <ExplanationTxt>CHANGE IN FAIR MARKET VALUE 0</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>